<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithrombin III (At-III) activity and protein, <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor activity, antifactor Xa activity were determined in 200 healthy adults, evenly distributed within age and sex groups, in 60 patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> and in 20 oral contraceptive users </plain></SENT>
<SENT sid="1" pm="."><plain>There was a positive correlation between At-III protein and its activities in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and in patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The mean At-III protein and <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor activity values decreased with age in men and in women of fertile age </plain></SENT>
<SENT sid="3" pm="."><plain>The mean values of At-III protein and its activities did not show any variation in the patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> when compared with the <z:mpath ids='MPATH_458'>normals</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>In oral contraceptive users a positive correlation was also found between At-III protein and its activities, antifactor Xa activity excepted </plain></SENT>
<SENT sid="5" pm="."><plain>The mean antifactor Xa activity value in these women decreased during treatment, whereas the other At-III activities and At-III protein were unchanged </plain></SENT>
</text></document>